A Clinical Trial to Assess the Efficacy of a Plant-based Energy Shot on Focus and ADHD-like Symptoms (NCT05857956) | Clinical Trial Compass
CompletedNot Applicable
A Clinical Trial to Assess the Efficacy of a Plant-based Energy Shot on Focus and ADHD-like Symptoms
United States40 participantsStarted 2023-02-24
Plain-language summary
This is a virtual, single-arm clinical trial that will last 28 days. Participants will drink 1 bottle of Proper Wild energy shot daily and complete questionnaires at baseline, day 1, day 14, and day 28.
Attention deficit hyperactivity disorder (ADHD)-like symptoms, such as concentration, focus, and attention, will be evaluated at baseline and at each check-in. Likert scale responses will be examined from baseline to each check-in. Participant responses on product feedback will be presented as % scores.
Who can participate
Age range18 Years – 55 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Currently experiencing symptoms associated with ADHD, including:
Impulsiveness. Disorganization and problems prioritizing Poor time management skills Problems focusing on a task Trouble multitasking Excessive activity or restlessness Poor planning
* Age 18-55
* Self-reported issues with focus and/or productivity
* Generally healthy - don't live with any uncontrolled chronic disease
Exclusion Criteria:
* Currently taking prescription medication for ADHD
* Currently supplementing with L-Theanine.
* Known to respond negatively to caffeine (no effect, makes them sleepy or feel unwell)
* People with a high caffeine tolerance defined as regular consumption of \>400mg of caffeine (\>4 coffees) per day.
* Any pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.
* Anyone with known severe allergic reactions.
* Women who are pregnant, breastfeeding, or attempting to become pregnant
* Unwilling to follow the study protocol.
What they're measuring
1
Change in Attention-deficit/hyperactivity disorder (ADHD)-like symptoms. [Time Frame: Baseline to Day 28]